Skip to content

Total debt at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$3.07B+1.9%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$140.18M+107%
TEC
Bio-TechneTECH
$290.32M-31.4%
Azenta logo
AzentaAZTA
$55.71M
Regenxbio logo
RegenxbioRGNX
$71.07M-11.0%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $410.7M.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's total debt?
Ginkgo Bioworks (DNA) reported total debt of $410.7M in Q1 2026.
How has Ginkgo Bioworks's total debt changed year-over-year?
Ginkgo Bioworks's total debt decreased by 5.5% year-over-year, from $434.56M to $410.7M.
What is the long-term trend for Ginkgo Bioworks's total debt?
Over 5 years (2020 to 2025), Ginkgo Bioworks's total debt has grown at a 92.8% compound annual growth rate (CAGR), from $16.52M to $439.89M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.